Physician profile
Matthew C Smith
NPI 1942542212
$6,096.89
in general payments reported to CMS, 2019-2025
8 companies · $208 in 2025
The $208 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $33.61 · 2021: $52.84 · 2022: $96.07 · 2024: $5,706 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,610 · Food and Beverage: $304.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,610.00 |
| Food and Beverage | $304.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Incorporated | $5,610.00 | 2024 | Zilver Ptx |
| Penumbra, INC. | $191.98 | 2021-2025 | Penumbra System |
| Shockwave Medical, INC | $82.51 | 2021-2024 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave M5+, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $55.00 | 2022 | |
| W. L. Gore & Associates, INC. | $52.47 | 2025 | Gore Tag Conformable Thoracic Endoprosthesis |
| Cook Medical LLC | $50.58 | 2024 | Cook |
| Genentech USA, INC. | $33.61 | 2019 | |
| Medtronic, INC. | $20.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.